Showing results (421-430 of 511) with videos related to
Sort By:
Pageof 52
The American Journal of Tropical Medicine and Hygiene|April 24, 2020
All together to Fight COVID-19Sara Momtazmanesh, Hans D Ochs, Lucina Q Uddin, et al.The Journal of Allergy and Clinical Immunology|December 14, 2011
Dendritic cells from X-linked hyper-IgM patients present impaired responses to Candida albicans and Paracoccidioides brasiliensisOtavio Cabral-Marques, Christina Arslanian, Rodrigo Nalio Ramos, et al.Scientific Reports|December 26, 2019
Publisher Correction: In Utero Gene Therapy (IUGT) Using GLOBE Lentiviral Vector Phenotypically Corrects the Heterozygous Humanised Mouse Model and Its Progress Can Be Monitored Using MRI TechniquesPanicos Shangaris, Stavros P Loukogeorgakis, Sindhu Subramaniam, et al.Blood|September 29, 2007
Long-term outcome following hematopoietic stem-cell transplantation in Wiskott-Aldrich syndrome: collaborative study of the European Society for Immunodeficiencies and European Group for Blood and Marrow TransplantationHulya Ozsahin, Marina Cavazzana-Calvo, Luigi D Notarangelo, et al.Nature Communications|July 19, 2016
Deletion of Wiskott-Aldrich syndrome protein triggers Rac2 activity and increased cross-presentation by dendritic cellsMarisa A P Baptista, Marton Keszei, Mariana Oliveira, et al.Scientific Reports|August 14, 2019
In Utero Gene Therapy (IUGT) Using GLOBE Lentiviral Vector Phenotypically Corrects the Heterozygous Humanised Mouse Model and Its Progress Can Be Monitored Using MRI TechniquesPanicos Shangaris, Stavros P Loukogeorgakis, Sindhu Subramaniam, et al.The New England Journal of Medicine|December 10, 2021
Betibeglogene Autotemcel Gene Therapy for Non-β0/β0 Genotype β-ThalassemiaFranco Locatelli, Alexis A Thompson, Janet L Kwiatkowski, et al.Nature Medicine|April 4, 2006
Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1Marion G Ott, Manfred Schmidt, Kerstin Schwarzwaelder, et al.Blood|January 12, 2026
Long-term efficacy and safety results of betibeglogene autotemcel gene therapy for transfusion-dependent β-thalassemiaJanet L Kwiatkowski, Alexis A Thompson, Jennifer Schneiderman, et al.Blood|July 24, 2024
Interleukin-1 blockade in patients with Wiskott-Aldrich syndrome: a retrospective multinational case seriesSamuele Naviglio, Maria Pia Cicalese, Elizabeth Rivers, et al.Pageof 52